Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management — Journal of Addiction Medicine (2020)• Drug: clorazepateDOI
- ASAM guideline on benzodiazepine tapering and prescribing — Journal of Addiction Medicine (2020)• Drug: clorazepateDOI
- FDA boxed warning update for benzodiazepines (abuse, addiction, dependence, withdrawal) — FDA Drug Safety Communication (2020)• Drug: clorazepateOpen access
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care — International Journal of Psychiatry in Clinical Practice (2012)• Drug: clorazepateDOI